Dishman Carbogen Amcis’ wholly owned subsidiary -- Carbogen Amcis AG. has successfully completed a Swissmedic inspection, performed by Regional Medicines Inspectorate of Western Switzerland (ISOPTh), of its facility in Vionnaz, Switzerland.
The two-day inspection took place from September 20 to 21, 2022 and was undertaken by an inspector of Regional Medicines Inspectorate of Western Switzerland (ISOPTh) at the Vionnaz, Switzerland site. The routine inspection covered the Quality Management System compliance and no critical deviation was raised. This inspection continues a series of successful inspections by Swissmedic in Vionnaz with the first inspection in 2015 followed by 2016, 2017 and 2020.
Dishman Carbogen Amcis provides innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries.
